You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for THIORIDAZINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for THIORIDAZINE

Average Pharmacy Cost for THIORIDAZINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
THIORIDAZINE 25 MG TABLET 00378-0614-01 0.52825 EACH 2025-02-19
THIORIDAZINE 10 MG TABLET 51079-0565-01 0.44498 EACH 2025-02-19
THIORIDAZINE 10 MG TABLET 51079-0565-20 0.44498 EACH 2025-02-19
THIORIDAZINE 25 MG TABLET 51079-0566-01 0.52825 EACH 2025-02-19
THIORIDAZINE 10 MG TABLET 00378-0612-01 0.44498 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Thioridazine

Introduction to Thioridazine

Thioridazine, a member of the phenothiazine antipsychotics drug class, is primarily used for the management of schizophrenic patients who have not responded adequately to other antipsychotic treatments. Here, we will delve into the market analysis, price projections, and other critical aspects of thioridazine.

Market Overview

The global antipsychotic drugs market, which includes thioridazine, is expected to grow steadily over the coming years. The market for antipsychotic drugs is projected to reach approximately $14.91 billion by 2025, growing at a CAGR of around 2.5% from 2017 to 2025[4].

Thioridazine Market Size and Growth

Specific data on the thioridazine market size is not as readily available as for the broader antipsychotic market. However, it is part of the larger psychotropic drugs market, which is anticipated to grow from $21,269.4 million in 2023 to $28,876.2 million by 2033, with a CAGR of 3.1% during the forecast period[5].

Price Analysis

The prices of thioridazine vary based on the dosage and quantity of the tablets.

Current Pricing

  • 10 mg Oral Tablet: The cost for 100 tablets can range from $55.55 to $57.98, with a per-unit price of $0.56 to $0.58[2].
  • 25 mg Oral Tablet: The cost for 100 tablets can range from $67.82, with a per-unit price of $0.68[2].
  • 50 mg Oral Tablet: The cost for 100 tablets can range from $77.37, with a per-unit price of $0.77[2].
  • 100 mg Oral Tablet: The cost for 100 tablets can range from $99.25, with a per-unit price of $0.99[2].

Price Projections

Given the stable demand for antipsychotic medications and the overall growth of the psychotropic drugs market, prices for thioridazine are likely to remain relatively stable or see moderate increases. However, specific price projections for thioridazine are not available, but it can be inferred that any changes will be in line with the broader market trends.

Market Segmentation and Applications

Types of Thioridazine

Thioridazine is available in various dosages, including 10 mg, 25 mg, 50 mg, and 100 mg oral tablets. The market segmentation by type focuses on these different dosages, each catering to different patient needs and treatment plans[2].

Applications of Thioridazine

Thioridazine is primarily indicated for the management of schizophrenic patients who have failed to respond adequately to treatment with other antipsychotic drugs. It is used as a last resort due to its potential for significant, possibly life-threatening, proarrhythmic effects[3].

Regional Market Analysis

The global thioridazine market is analyzed across various regions, including North America, Europe, China, Japan, and the Middle East & Africa. Each region has its own production value, consumption patterns, and market forecasts.

  • North America: This region is a significant market for thioridazine, driven by advanced healthcare infrastructure and high demand for antipsychotic medications.
  • Europe: Europe also represents a substantial market, with a focus on both production and consumption of thioridazine.
  • China and Japan: These countries are important in the Asia-Pacific region, with growing demand for psychotropic drugs, including thioridazine[1].

Competitive Landscape

The market for thioridazine is part of the highly competitive antipsychotic and psychotropic drugs market. Several key players operate globally, focusing on innovations, better quality products, and expanded product lines. The competitive landscape is driven by these players' strategies to offer unique and advanced products to consumers[5].

Challenges and Risks

Safety Concerns

Thioridazine is associated with significant risks, including the prolongation of the QTc interval, which can lead to serious, potentially fatal, ventricular arrhythmias such as Torsades de pointes. This risk necessitates careful patient selection and monitoring[3].

Regulatory Considerations

Due to its potential for serious side effects, thioridazine is subject to strict regulatory guidelines. It is contraindicated with certain drugs that inhibit cytochrome P450 2D6 and in patients with reduced activity of this isozyme[3].

Future Outlook

The future outlook for thioridazine is tied to the broader trends in the antipsychotic and psychotropic drugs market. Here are some key points:

  • Market Growth: The psychotropic drugs market, which includes thioridazine, is expected to grow at a CAGR of 3.1% from 2023 to 2033[5].
  • Innovations: Continued innovations in antipsychotic medications may impact the demand for thioridazine, as newer drugs with better safety profiles and efficacy may become available.
  • Regulatory Environment: Strict regulatory oversight will continue to shape the market for thioridazine, ensuring its use is limited to patients who have failed other treatments.

Key Takeaways

  • Market Size and Growth: Thioridazine is part of a larger market expected to grow significantly over the next decade.
  • Price Stability: Prices for thioridazine are likely to remain stable or see moderate increases.
  • Regional Analysis: The market is segmented across various regions, each with its own production and consumption patterns.
  • Safety Concerns: Thioridazine is associated with significant safety risks, necessitating careful use.
  • Regulatory Environment: Strict regulations govern the use of thioridazine due to its potential side effects.

FAQs

What is the primary use of thioridazine?

Thioridazine is primarily used for the management of schizophrenic patients who have not responded adequately to treatment with other antipsychotic drugs[3].

What are the potential risks associated with thioridazine?

Thioridazine can prolong the QTc interval, leading to serious, potentially fatal, ventricular arrhythmias such as Torsades de pointes[3].

How does the price of thioridazine vary by dosage?

The price of thioridazine varies by dosage, with 10 mg tablets costing around $55.55 to $57.98 for 100 tablets, and higher dosages costing more accordingly[2].

What is the market outlook for thioridazine?

The market for thioridazine is expected to grow as part of the broader psychotropic drugs market, with a CAGR of 3.1% from 2023 to 2033[5].

Are there any regulatory restrictions on the use of thioridazine?

Yes, thioridazine is subject to strict regulatory guidelines due to its potential for serious side effects and is contraindicated with certain drugs and in patients with reduced cytochrome P450 2D6 activity[3].

Sources

  1. Global Thioridazine Hydrochloride Industry Market Report 2019 - Market Research Store
  2. Thioridazine Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Thioridazine: Package Insert / Prescribing Information - Drugs.com
  4. Global Antipsychotic Drugs Market Analysis & Trends 2014-2016 - Business Wire
  5. Psychotropic Drugs Market is expected to reach US$ 28,876.2 million by 2033 - GlobeNewswire

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.